Your Funds at Work

Funds raised go to the Sarcoma Foundation of America to support sarcoma research nationally and locally. Fifty percent of the net proceeds support the University of Pittsburgh Cancer Institute Sarcoma Research Fund through arestricted sarcoma research grant. The other fifty percent of net proceeds are delegated to sarcoma research grants throughout the country, at the discretion of the SFA. In total,Pittsburgh Cure Sarcomaraces have funded seven sarcoma research grants through the SFA:

2013

  • Pittsburgh 5K Cure Sarcoma Research Grant
  • Brian Van Tine, MD, PhD
  • Washington University, St. Louis
  • “A metabolomic approach to targeting ASS1 deficient sarcomas”

2014

  • Pittsburgh 5K Cure Sarcoma Research Grant
  • Liang-Chuan Wang, PhD
  • University of Pennsylvania
  • “CAR T Cell Therapy for Sarcoma”

2015

  • Pittsburgh Cure Sarcoma Co-Founder Carl Firetto Memorial Research Award
  • MeenakshiHegde, MD
  • Baylor College of Medicine
  • “Adoptive cellular therapy for Ewing’s sarcoma”
  • Pittsburgh Cure Sarcoma Co-Founder Bill Suit Memorial Research Award
  • Steven Katz, MD
  • Roger Williams Hospital
  • “Pre-clinical development of anti-KIT CAR-Ts for metastatic GIST”

2016

  • Pittsburgh Cure Sarcoma Co-Founder Carl Firetto Memorial Research Award
  • William Karl Decker, PhD
  • Baylor College of Medicine
  • “Outbred Canine Model of Adjuvant Immunotherapy for Angiosarcoma”
  • Pittsburgh Cure Sarcoma Co-Founder Bill Suit Memorial Research Award
  • Lionel Mu-Lo Chow, MD, PhD
  • Cincinnati Children’s Hospital Medical Center
  • “A Novel Genetically Engineered Mouse Model for Angiosarcoma: Molecular Characterization and Comparison to Human Angiosarcoma to Develop Targeted Therapy”

2017

  • Pittsburgh Cure Sarcoma Research Award
  • Cheryl London, DVM, PhD
  • Tufts Medical Center
  • “Interrogating the regulation, function and therapeutic potential of monocarboxylate transporters in osteosarcoma”